Arkolith/Insider Trading/SMMT/Form 4

Dhingra Ankur

Chief Financial OfficerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Dec 13, 2023
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2023Buy(P)700$2.15$2K235K
Dec 13, 2023Buy(P)20K$2.17$43K255K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-23-000101) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML